DUBLIN, Feb. 15, 2024 /PRNewswire/ — The “Technology Advancements in Precision Diagnostics and Testing” report has been added to ResearchAndMarkets.com’s offering.
Precision diagnosis in today’s healthcare is pivotal, tailoring treatment to individual patients based on genetic, molecular, and environmental factors. This targeted approach enhances accuracy, enables early detection and targeted treatment, minimizes trial-and-error treatment, and optimizes therapeutic outcomes.
By leveraging advanced technologies and personalized data, precision diagnosis empowers healthcare professionals to make informed decisions, improving patient care and fostering more effective and efficient healthcare delivery.
Cutting-edge precision diagnostic technologies are transforming the medical science and patient care landscape. These advanced methods meticulously analyze biological samples, such as blood, tissue, and genetic material, to accurately diagnose a range of diseases and conditions. The importance of precision diagnostic technology in healthcare lies in its ability to precisely identify diseases, reduce misdiagnoses, prevent unnecessary treatment, and enhance the effectiveness of targeted therapies. Ultimately, this contributes to improved patient outcomes.
Technology advancements around genomic sequencing, multi-omics, and AI and Big Data integration have boosted this space’s growth.
This research service focuses on identifying different emerging technologies that enable precision diagnosis, key participants working on different technologies, and the applicability of precision diagnosis across different disease areas.
The report identifies 3 growth opportunities for precision diagnosis that could potentially transform the market.
Top 3 Growth Opportunities
Increased Adoption of Genomic Screening
Big Data and AI Augmentation
Discovery of Novel Biomarkers
Key Questions Answered
What are the drivers and challenges for precision diagnostics and testing development?
How can precision diagnosis transform diagnosis across different disease areas?
What does the mitochondrial therapeutics funding and partnership scenario look like?
Who are the main precision diagnostics and testing innovators?
What are the R&D trends in this space?
What are the key growth opportunities?
Key Market Dynamics
Public and Private Funding are Promoting Precision Diagnostics Development
Precision Diagnostics Companies’ Partnerships
Key Topics Covered:
Growth Opportunity Analysis
Growth Drivers
Growth Driver Analysis
Growth Restraints
Growth Restraint Analysis
Scope and Segmentation
Utility of Precision Diagnostics
Liquid Biopsy in Precision Diagnosis
Predictive Genetic Testing as an Effective Tool for Precision Testing
Pharmacogenomics in Precision Diagnosis
Technological Advancements in PCR
Emerging Technologies Bolstering Precision Testing
Emerging Technologies Enabling Precision Testing/Diagnosis
Precision Diagnostics: Application across Different Diseases
The Role of Precision Testing in Oncology
Technologies Enabling Precision Testing/Diagnosis for Oncology
Novel Biomarkers Enabling Precision Medicine
Microfluidic Devices Enabling Precision Medicine
Innovation Spotlight – Precision Testing Technology for Oncology
Recent CDx Approvals – Cancer Therapy Selection
Infectious Diseases – The Need for Precision Testing
Precision Testing Enables Infectious Disease Surveillance and Management
Emerging Technologies for the Precision Testing of Infectious Diseases
Molecular Diagnostics Enabling Precision Testing/Diagnosis for Infectious Diseases
Multiplex Molecular POC Testing Enabling Precision Medicine
Innovation Spotlight – Precision Testing Technology for Infectious Diseases
Neurological Diseases – Challenges with Diagnostics
How Precision Testing Helps Overcome Current Diagnostic Challenges
Blood-based Biomarkers to Improve Neurodegenerative Disease Assessment
Technologies Enabling Precision Testing/Diagnosis for Neurological Diseases
Innovation Spotlight – Precision Testing Technology for Neurological Diseases
CVDs – Current Testing Challenges and the Way Forward
Molecular Diagnostics Enabling Precision Testing/Diagnosis for CVDs
Innovation Spotlight – Precision Testing Technology for Neurological Diseases
Genetic/Rare Diseases – Challenges With Diagnosis
How Precision Testing Helps Overcome Current Diagnostic Challenges in Genetic/Rare Diseases
Technologies Enabling Precision Testing/Diagnosis for Genetic/Rare Diseases
Enablers of Precision Diagnostics
Enablers of Precision Diagnosis
AI and ML in Precision Testing
Application
Big Data Analytics in Precision Testing
R&D Focus
Strategic Imperatives to Bolster Precision Testing
For more information about this report visit https://www.researchandmarkets.com/r/357tpw
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
